Evidence map›Paper›PMID 38252911›Full record

ArticleJCO oncology practice2024

Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL.

Julie A Wolfson, Allison C Grimes, Michelle Nuno, Charlotte L Kerber, Subhash Ramakrishnan, Melissa Beauchemin, David Dickens, Jennifer M Levine, Michael E Roth, Michele Scialla and 14 more

Abstract read
In one paragraph

Article in JCO oncology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Julie A WolfsonDivision of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-3711-2239
Allison C GrimesDivision of Pediatric Hematology-Oncology, University of Texas Health Science Center San Antonio, San Antonio, TX.
Michelle NunoChildren's Oncology Group, Arcadia, CA.ORCID 0000-0003-2031-929X
Charlotte L KerberDepartment of Public Health Sciences, University of California, Davis, CA.ORCID 0000-0003-3937-2736
Subhash RamakrishnanChildren's Oncology Group, Arcadia, CA.
Melissa BeaucheminSchool of Nursing, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0003-4058-1586
David DickensDivision of Pediatric Hematology-Oncology, University of Iowa, Iowa City, IA.ORCID 0000-0001-8821-6022
Jennifer M LevineCenter for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC.ORCID 0000-0003-1417-0169
Michael E RothDivision of Pediatric Hematology-Oncology, MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-6411-8353
Michele SciallaDivision of Pediatric Hematology-Oncology, Nemours, Wilmington, DE.ORCID 0000-0001-7933-0675
Wendy WoodsDivision of Pediatric Hematology-Oncology, Blank Children's Hospital, Des Moines, IA.ORCID 0000-0002-6280-5360
Sarah VargasChildren's Oncology Group, Arcadia, CA.
Koh B BoayueDivision of Pediatric Hematology-Oncology, University of New Mexico Cancer Center, Albuquerque, NM.
George J ChangAlliance Cancer Care Delivery Research, Houston, TX.ORCID 0000-0002-9758-5361
Wendy StockAlliance Leukemia, Chicago, IL.ORCID 0000-0002-8349-9200
Dawn HershmanSWOG Cancer Care Delivery Research, Portland, OR.ORCID 0000-0001-8807-153X
Emily CurranAlliance Leukemia, Cincinnati, OH.
Anjali AdvaniSWOG Leukemia, Portland, OR.ORCID 0000-0003-0015-5902
Kristen O'DwyerSWOG Leukemia, Portland, OR.ORCID 0000-0001-8517-8198
Selina LugerECOG-ACRIN Leukemia, Boston, MA.ORCID 0000-0003-3364-4366
Jane Jijun LiuAlliance Community Oncology, Chicago, IL.
David R FreyerDivision of Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, CA.ORCID 0000-0001-5280-990X
Lillian SungDivision of Pediatric Hematology-Oncology, The Hospital for Sick Children, Toronto, ON (Canada).ORCID 0000-0003-0951-3091
Susan K ParsonsDivision of Hematology/Oncology and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.ORCID 0000-0003-0282-6490

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Collaborations and NCORP Collective ManagementUG1CA189823 · NCI · MAYO CLINIC ROCHESTER · PI Evanthia Galanis, Olwen Hahn · 2014 to 2026
$120.6M
SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ANDERSON, JAMES R · 2003 to 2013
$67.5M
Towards a preventive cancer vaccine for children with constitutional mismatch repair deficiencyUG1CA189955 · NCI · PUBLIC HEALTH INSTITUTE · PI BRAD H POLLOCK, Michael E. Roth · 2014 to 2026
$62.5M
NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCI NIH HHS UG1 CA189823NCI NIH HHS UG1 CA189828NCI NIH HHS UG1 CA189955NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

purposeIndividuals diagnosed with cancer between 15 and 39 years (adolescent and young adult [AYA]) face unique vulnerability. Detail is lacking about care delivery for these patients, especially those with ALL. We address these knowledge gaps by describing AYA ALL care delivery details at National Cancer Institute Community Oncology Research Program (NCORP) (sub)affiliates by model of care.

methodsParticipating institutions treated at least one AYA with ALL from 2012 to 2016. Study-specific criteria were used to determine the number of unique clinical facilities (CFs) per NCORP and their model of care (adult/internal medicine [IM], pediatric, mixed [both]). Surveys completed by NCORPs for each CF by model of care captured size, resources, services, and communication.

resultsAmong 84 participating CFs (adult/IM, n=47; pediatric, n=15; mixed, n=24), 34% treated 5-10 AYAs with ALL annually; adult/IM CFs more often treated <5 (adult/IM, 60%; pediatric, 40%; mixed, 29%). Referral decisions were commonly driven by an age/diagnosis combination (58%), with frequent ALL-specific age minimums (87%) or maximums (80%). Medical, navigational, and social work services were similar across models while psychology was available at more pediatric CFs (pediatric, 80%; adult/IM, 40%; mixed, 46%-54%). More pediatric or mixed CFs reported oncologists interacting with pediatric/adult counterparts via tumor boards (pediatric, 93%; adult/IM, 26%; mixed, 96%) or initiating contact (pediatric, 100%; adult/IM, 77%; mixed 96%); more pediatric CFs reported an affiliated counterpart (pediatric, 53%; adult, 19%). Most CFs reported no AYA-specific resources (79%) or meetings (83%-98%).

conclusionSystem-level aspects of AYA ALL care delivery have not been examined previously. At NCORPs, these characteristics differ by models of care. Additional work is ongoing to investigate the impact of these facility-level factors on guideline-concordant care in this population. Together, these findings can inform a system-level intervention for diverse practice settings.

Indexed as

NeoplasmsOncologistsAdolescentChildDelivery of Health CareHumansSurveys and QuestionnairesYoung Adult

Identifiers

PMID38252911
PMCPMC11085951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.